Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank9
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P9
Near historical low
vs 3Y Ago
-2.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-86.70M-14.1%
2024$-75.99M+67.7%
2023$-235.03M-690.0%
2022$39.84M+872.4%
2021$-5.16M+92.1%
2020$-65.59M-26.6%
2019$-51.80M+17.6%
2018$-62.87M+0.8%
2017$-63.37M-85.5%
2016$-34.16M-